Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVS HEALTH Corp Director's Dealing 2021

May 6, 2021

29875_dirs_2021-05-06_bad9d84a-e6ff-4a65-bfe0-834439f1d4f4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2021-05-04

Reporting Person: Boratto Eva C (EVP & CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-05-04 Common Stock S 4905 $80.00 Disposed 115331.0445 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock (restricted) 2242 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $102.26 2022-04-01 Common Stock (27392) 27392 Direct
Stock Option $104.82 2023-04-01 Common Stock (21509) 21509 Direct
Stock Option $78.05 2024-04-03 Common Stock (35062) 35062 Direct
Stock Option $62.21 2025-04-01 Common Stock (35030) 35030 Direct
Stock Option $54.19 2029-04-01 Common Stock (202007) 202007 Direct
Stock Option $58.34 2030-04-01 Common Stock (168956) 168956 Direct
Stock Option $74.30 2031-04-01 Common Stock (103663) 103663 Direct

Footnotes

F1: All sales were effected pursuant to a Rule 10b5-1 plan.

F2: Option became exercisable in four equal annual installments, commencing 4/1/2016.

F3: Option becomes exercisable in four equal annual installments, commencing 4/1/2017.

F4: Option became exercisable in four equal annual installments, commencing 4/3/2018.

F5: Option became exercisable in four equal annual installments, commencing 4/1/2019.

F6: Option became exercisable in four equal annual installments, commencing 4/1/2020.

F7: The number of shares subject to the option were calculated using a 30-day average price.

F8: Options became exercisable in four equal annual installments, commencing 4/1/2021.

F9: Option becomes exercisable in four equal annual installments, commencing 4/1/2022.